Insider · CIK 0002011728
Ryan H. Saadi
Files at TVGN (Tevogen Bio Holdings Inc.). First filing Jun 9, 2025, latest Jun 9, 2025.
In brief
Ryan H. Saadi files SEC Form 4 as CEO, director and 10% owner at TVGN (Tevogen Bio Holdings Inc.). Since Jun 9, 2025, Ryan H. Saadi has reported 0 open-market buys worth $0 and 1 open-market sell worth $1.8M, the latest filed on Jun 9, 2025.
A track record needs three past buys with six months of prices behind them; Ryan H. Saadi has 0, so none is measured yet.
The newest scored trade: sold $1.8M of TVGN on Jun 9, 2025, filed Jun 9, 2025, scored 50 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TVGN: Tevogen Bio Holdings Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | TVGNsell Tevogen Bio Holdings Inc. | $1.8M 1,438,206 shares | -1% | +325% from low-64% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 9, 2025 | TVGN Tevogen Bio Holdings Inc. | 1,438,206 0.78% of outstanding | $1.6M | Jun 9, 2025 | none |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | TVGN Tevogen Bio Holdings Inc. | AGrant or award Common Stock | +8,000,000 | $0.00 | $0 | 11,705,689 | 28 d ago |
| Jul 10, 2026 | TVGN Tevogen Bio Holdings Inc. | AGrant or award Common Stock | +1,220,000 | $0.00 | $0 | 3,705,689 | Jul 10, 2026 |
| Dec 18, 2025 | TVGN Tevogen Bio Holdings Inc. | GGift Common Stock | -50,000 | $0.00 | $0 | 124,284,453 | Dec 22, 2025 |
| Dec 11, 2025 | TVGN Tevogen Bio Holdings Inc. | GGift Common Stock | -460,000 | $0.00 | $0 | 124,334,453 | Dec 12, 2025 |
| Aug 15, 2025 | TVGN Tevogen Bio Holdings Inc. | GGift Common Stock | -20,000 | $0.00 | $0 | 124,794,453 | Aug 18, 2025 |
| Jun 27, 2025 | TVGN Tevogen Bio Holdings Inc. | AGrant or award Common Stock | +8,000,000 | $0.00 | $0 | 124,814,453 | Jul 1, 2025 |
| Jun 9, 2025 | TVGN Tevogen Bio Holdings Inc. | SOpen-market sale Common Stock | -1,438,206 | $1.23 | $1.8M | 116,814,453 | Jun 9, 2025 |
| Feb 14, 2024 | TVGN Tevogen Bio Holdings Inc. | AGrant or award Common Stock | +98,901,098 | - | - | 98,901,098 | Feb 16, 2024 |
| Feb 14, 2024 | TVGN Tevogen Bio Holdings Inc. | AGrant or award Common Stock | +19,348,954 | $0.00 | $0 | 118,250,052 | Feb 16, 2024 |
| Feb 14, 2024 | TVGN Tevogen Bio Holdings Inc. | AGrant or award Common Stockindirect: By wife | +193,923 | - | - | 193,923 | Feb 16, 2024 |
Questions about Ryan H. Saadi
Answered from the filings on this page, as of the latest one.
Is Ryan H. Saadi buying or selling?
Not in the last 12 months. Ryan H. Saadi's latest open-market trade on SEC Form 4 was sold $1.8M of TVGN on Jun 9, 2025.
How did Ryan H. Saadi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ryan H. Saadi has 0.
Where does Ryan H. Saadi file Form 4?
Ryan H. Saadi has filed Form 4 at TVGN (Tevogen Bio Holdings Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.